Bain Capital Life Sciences

What they do

Bain Capital Life Sciences specializes in buyouts, inflexion capital, growth capital, turnaround investments, and private equity. It invests in pharmaceutical, biotechnology, medical device, diagnostic, and life science tool companies across the globe, with a focus on companies that both drive medical innovation across the value chain and enable that innovation to improve the lives of patients with unmet medical needs. The differentiated skillset of the Bain Capital Life Sciences team enables it to deliver targeted capital and value-added strategic support to companies around critical phases of growth and inflexions in value.

What they look for

BCLS focuses on driving medical innovation to improve the lives of patients with unmet medical needs. They explicitly target four types of investment opportunities: Inflection Capital, Growth Capital, Fallen Angels, and Transformation at Scale. They look for companies entering the "Critical Value Creation Period" (CVCP)-the inflection point where the probability of success transitions from <10% to >50% (typically post-Proof of Concept), seeking strong clinical data and assets with best-in-class or first-in-class potential.

Stage

Series A, Series B+

Sectors

Healthcare

Based

Boston, US